FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC) Print this page Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation (CIC).1 Motegrity, a… Read More »
Brief Published Dec. 19, 2018 Dive Brief: Consumers are getting “mixed messages” from the CMS Hospital Compare website and penalties levied by the Hospital Readmissions Reduction Program, undermining their ability to shop for quality care, according to a study in The American Journal of Managed Care. The researchers compared hospital grades posted on Hospital Compare for… Read More »
Policies aimed at removing sweets and crisps from checkouts could lead to a dramatic reduction to the amount of unhealthy food purchased to eat ‘on the go’ and a significant reduction in that purchased to take home, suggests new research led by the University of Cambridge. The study, published in the journal PLOS Medicine, found… Read More »
It has been known for some time that obese people are at increased symptoms for more severe symptoms and complications if they get the flu. Now it has been reported that obese people are also likely to remain sick and infectious long than those who are not obese. This is another reason for you,… Read More »